Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NOV
NOV logo

NOV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nov Inc (NOV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
18.840
1 Day change
-0.63%
52 Week Range
20.860
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Based on the data provided, NOV Inc. is not a strong buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, technical indicators are mixed, and there are no strong positive catalysts or trading signals to justify immediate investment. Holding off for better clarity or improvement in fundamentals is advised.

Technical Analysis

The MACD is negative and expanding downward (-0.18), indicating bearish momentum. RSI is at 27.698, which is neutral but approaching oversold territory. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level (19.891), suggesting resistance ahead. Support levels are at 19.12 and 18.643, with resistance at 20.663 and 21.14.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • Some analysts have raised price targets to $20-$23, indicating potential upside. The company's new CEO is working to reposition the portfolio, which could yield long-term benefits.

Neutral/Negative Catalysts

  • Q4 financials showed significant declines in revenue (-1.34% YoY), net income (-148.75% YoY), and EPS (-151.22% YoY). Gross margin also dropped (-7.68% YoY). Analysts have mixed ratings, with several maintaining Neutral or Sell ratings. No recent news or significant insider/hedge fund trading activity.

Financial Performance

In Q4 2025, revenue dropped to $2.277 billion (-1.34% YoY), net income fell to -$78 million (-148.75% YoY), EPS declined to -0.21 (-151.22% YoY), and gross margin decreased to 19.72% (-7.68% YoY). These metrics indicate weak financial performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. While some firms raised price targets to $20-$23, others maintain Neutral or Sell ratings. The consensus reflects uncertainty about the company's near-term prospects, with some optimism for long-term structural improvements.

Wall Street analysts forecast NOV stock price to rise
11 Analyst Rating
Wall Street analysts forecast NOV stock price to rise
5 Buy
5 Hold
1 Sell
Moderate Buy
Current: 18.960
sliders
Low
16
Averages
19.18
High
23
Current: 18.960
sliders
Low
16
Averages
19.18
High
23
Goldman Sachs
Ati Modak
Sell
maintain
$17 -> $20
AI Analysis
2026-03-04
Reason
Goldman Sachs
Ati Modak
Price Target
$17 -> $20
AI Analysis
2026-03-04
maintain
Sell
Reason
Goldman Sachs analyst Ati Modak raised the firm's price target on NOV Inc. to $20 from $17 and keeps a Sell rating on the shares. While geopolitical risks could create near-term challenges, there are early signs of dislocations which could present opportunities when compared to fundamentals, the analyst tells investors in a research note. The firm does not expect current geopolitical concerns to meaningfully impact long-term customer plans as significant portions of the activity increases are structural in offsetting decline rates and increasing production capacity, the firm says.
Citi
Neutral
maintain
$17 -> $20
2026-02-11
Reason
Citi
Price Target
$17 -> $20
2026-02-11
maintain
Neutral
Reason
Citi raised the firm's price target on NOV Inc. to $20 from $17 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NOV
Unlock Now

People Also Watch